AstraZeneca- MSD gets EU nod for Lynparza to treat early-stage breast cancer Ruchika Sharma5 Aug 2022 5:23 PM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
Sacral neuromodulation effective against neurogenic lower urinary tract dysfunction: NEJM Jacinthlyn Sylvia12 July 2022 8:00 PM ISTSacral neuromodulation (SNM) significantly treated refractory neurogenic lower urinary tract dysfunction (NLUTD) in well-selected neurologic patients...
Maternal vaccination lowers risk of COVID-19-associated hospitalization in infants: NEJM Dr. Hiral patel30 Jun 2022 7:30 PM ISTUSA: Completion of a 2-dose primary mRNA COVID-19 vaccination series during pregnancy is associated with a reduced risk of hospitalization for...
Vitamin C administration worsens outcomes of sepsis patients on vasopressor therapy: NEJM Jacinthlyn Sylvia16 Jun 2022 8:38 PM ISTUSA: In a new study published in The New England Journal of Medicine shows that adults with sepsis following vasopressor therapy in the ICU had a...
Tirzepatide new treatment option for people who are overweight or have obesity: SURMOUNT-1 clinical trial Dr. Kamal Kant Kohli6 Jun 2022 9:45 AM ISTIn the 72-week, phase III SURMOUNT-1 clinical trial the researchers have reported that combination GIP and GLP-1 receptor agonist tirzepatide...
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Hypomethylating agents Could Activate "Sleeping" Cancer-Causing Gene: NEJM Medical Dialogues Editorial Team26 May 2022 9:15 PM ISTChina: Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) -and increasingly in...
FDA Approves tapinarof cream- first nonsteroidal treatment for plaque psoriasis Dr. Kamal Kant Kohli26 May 2022 10:00 AM ISTThe Food and Drugs Administration has approved Vtama cream for treating plaque psoriasis with varying severity. The approval was announced by...
Should surgery be opted for Achilles Tendon rupture? Study says no benefit Medical Dialogues Editorial Team18 May 2022 7:00 PM ISTNorway: In a new study conducted by Stale B. Myhrvold it was seen that at 12 months, surgery (minimally invasive surgery or open repair) was not...
CV risk factors in childhood linked to hard CV disease outcomes in adulthood: NEJM MD Bureau7 May 2022 9:00 AM ISTPrevention of cardiovascular disease remains a major public health issue, with well-documented associations between cardiovascular risk factors in...
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use Ruchika Sharma6 May 2022 5:08 PM ISTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
Recombinant plant-based Covid-19 vaccine promising for infection control: NEJM Medical Dialogues Editorial Team6 May 2022 10:06 AM ISTCanada: In a new study conducted by Karen J. Hager and team, it was shown that the Coronavirus-like particles (CoVLP) + Adjuvant System 03 (AS03)...
